Professional Documents
Culture Documents
BLEEDING
SPONTANEOUS ABORTION
?30%, usu self-limited
ECTOPIC PREGNANCY
?1%, most dangerous
MOLAR PREGNANCY
0.1%, cookbook
SPONTANEOUS ABORTION
RISK FACTORS
AGE
10%@20, 20%@35, 40%@40, 80%@45
SAB HX
5% NSVD/NO SAB, 30-40% IF 3 SABS
CAUSES
APPROACH
ESTABLISH IUP-R/O ECTOPIC-urgent
ECTOPIC? VIABILITY?
RISK FACTOR ASSESSMENT
absence doesnt r/o
ECTOPIC? VIABILITY?
HCG
?serial- not if visualized on sono
?serial sono better if not definitive
SONOGRAPHY
Gest sac/yolk sac- ?normal appearing
Fetal pole if gest sac MSD >20
cardiac if fetal pole >6-7wk=CRL >5mm
TERMS
THREATENED-next slide
INEVITABLE-open,SROM,heavy bleeding
INCOMPLETECOMPLETE-easiest in retrospect-decresc
MISSED/ BLIGHTED OVUM
SEPTIC
Threatened SAB
Vaginal bleeding +/- cramping
30-40% pregnancies bleed; 1/2 SAB
more symptoms, small for dates,
subchorionic bleed-poorer prognosis
fetal cardiac activity- better prognosis
Rx- observation
INTERVENTION
DO I NEED TO INSTRUMENT?
Where/ what instrument?
How soon?-septic vs bleeding vs missed
Lams? EGA by sono, blighted ovum
OPTIONS
EXPECTANT
<10-12wk, 80-90% res, slower
SURGICAL
?ectopic, septic, BLEEDING, missed,>10-12
Fastest
MEDICAL
<10-12, 80-90% res, faster
Miso 600-800 PV x 1-2
PREVENT
ISOIMMUNIZATION
REMEMBER RHOGAM
50mcg IM if < 12 WEEKS
300mcg IM IF > 12 WEEKS
Recurrent SAB
?3 consecutive for therapeutic nihilists
?evid base for recommendations
Outcomes similar- ~70% successful preg
no w/u, + or w/u , +w/u with or without rx
50% success after 6 consecutive losses
MOLAR PREGNANCY
Aberrant fertilization, fetal origin
0.05-0.1% incid (US), chorioca 1:30,000
1:120 SE Asians, 1:1200 Hispanics, prior
mole, age <20 >35, lower parity
80-90% benign course
most metastatic disease curable
CLASSIFICATION
HYDATIDIFORM MOLE =GTD
COMPLETE
PARTIAL
PERSISTENT/INVASIVE MOLE=GTN
CHORIOCARCINOMA=GTN
PLAC SITE TROPHOBLASTIC TUMOR=
GTN
Fetal tissue
2 sperm + 1 ovum 69XXY or 69XYY
GTN risk 5%
CLINICAL FINDINGS
VAGINAL BLEEDING
NO FHTS
SIZE > DATES
HIGH HCG- >100,000 (nl preg peak < 200,000)
HYPEREMESIS GRAVIDARUM
EARLY PREECLAMPSIA <20Wwks
THYROTOXICOSIS
OVARIAN CYTS ( THECA LUTEIN)
DIAGNOSIS
SONOGRAPHY
PATHOLOGY
W/U
HCG, Rh, TSH, LFP, BUN/Cr
CXR
SONO
TREATMENT
Uterine evacuation
D&C, pitocin running?
Bleeding, perforation, ?ARDS, etc
Serial HCGs
q wk till negative then q mo for 6-12mo
Should drop rapidly& be negative < 90 days
normal preg usu takes 2-4wk
Pelvic sono
Consider repeat D&C- up to 40% neg HCG
Cbc, coags, liver, renal labs
CT abd, pelvis, chest, ?head
GTN
Occurs 50% after nl preg, 25% after mole,
25% after ectopic/SAB
Vag bleeding or amenorrhea esp prolonged
postpartum,very bloody tumors check
HCG
Serial HCGs after molar pregs
Remember rhogam
300mcg IM with moles
ECTOPIC PREGNANCY
Risk factors
Tubal damage
Prior ectopic
PID 1:24 pregs
pelvic surg- appi, cystectomy, section, TL
Failed contraception
IUD, progesterone only methods, TL, emergency?
Misc.
extrinsic mass, infert, smoking at conception
Clinical Presentation
-an evolution Pregnancy
amenorrhea, N, V, frequency, rising HCG
Failing pregnancy
vag bleeding, ?tissue, flat/ falling HCG
HCG
Increase in HCG
(percent)
29
66(53)
114
174
255
Sonography
Primary-Verify or rule out IUP-?heterotopic
Also ectopic cardiac, complex mass, free fluid
Discriminatory zone
Endovaginal vs. transabdominal
Availability
Indication-low thresholds symptoms-All?
Sonography
continued
Gestational sac (vs pseudo sac)
EGA~5wks, singleton 1000-1800
Fetal pole
EGA~5.5wks, by mean sac diam of 16-20mm
Cardiac activity
EGA~6wks, by 7 wks minimum EGA or fetal
pole >5mm
DDX
SAB
Molar preg
IUP complicated by:
DIAGNOSTIC ALGORITHM
S U R G IC A L
EM ER G EN C Y
SU R G ER Y
DIAGNOSTIC ALGORITHM
? S U F F IC IE N T H C G
SO N O G R AM
IU P V S E M P T Y
DIAGNOSTIC ALGORITHM
? IN S U F F IC IE N T H C G
R IS IN G H C G
S E R IA L Q U A N T S
E C T O P IC P R E C A U T IO N S
S O N O A T D IS C R IM IN A T O R Y Z O N E
DIAGNOSTIC ALGORITHM
F L A T / F A L L IN G H C G
U N D E S IR E D P R E G N A N C Y
PR O G ESTER O N E < 5
U T E R IN E E V A C U A T IO N
F R O Z E N S E C T IO N
C H O R IO N IC V IL L I
VS
D E C ID U A
Treatment options
Expectant
Methotrexate
Surgery
Expectant
Selection criteria
asymptomatic, small ectopic, low falling HCG
Rationale
?incidence tubal SAB, no therapeutic M&M
Concerns
risk of rupture awaiting resolution
Methotrexate
Inclusion criteria
<3-4cm, unruptured, no liver, renal, heme dis ?
no cardiac activity, ?HCG <5000-15,000
Education/ consent
Workup
CBC/d, AST, BUN/Cr,Type/Rh
Sono
D&C
Methotrexate
informed consent
Alternatives
nature of treatment & follow-up
failure rate, risk of rupture
Side-effect profile
pain, stomatitis, liver, marrow, renal tox
things to avoid
NSAIDs, ETOH, folic acid, intercourse
Methotrexate
Dose
50mg/m2
Follow-up
quant HCG 3&6 days after injection
Success
>15% drop on HCG between day 3&6
follow weekly till negative
ALT METHOTREXATE
1mg/kg IM every other day to 4 doses
Quant HCG with leucovorin rescue on
alternate days
Stop when 15% drop in HCG
?higher efficacy, less lost sleep
Surgery
Laparoscopy vs laparotomy
Conservative- maximize fertility
salpingostomy